ARCHIVES

Avastin improves lung cancer survival, opens options for new combinations. Details of Avastin risk vs. benefit to be released at ASCO annual meeting.

This article is from The Cancer Letter archive.

Vol. 31 No. 13 | April 1, 2005

Download PDF Visit The Full Archive

Related Articles

Highlights of NCDDGs: 3 Drugs on Market, 12 in Development; Advisors Approve Plan to Issue $10.5 Million Contract For Pediatric Preclinical Testing Program

November 29, 2002

BSA Approves Six Concepts

July 19, 2013

NCI considers allowing some centers to opt out of site visits.

March 19, 2004

Three Geneticists Of “Knockout” Mice Fame Win Lasker Award For Basic Research.

September 28, 2001

House Members Who Voted for Veto

January 3, 1986

In Brief: Emory Univ. Receives $295 Million Endowment; Winship Cancer Center To Get Half of Income

August 16, 1996